510 related articles for article (PubMed ID: 33272643)
1. Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial.
Lee MK; Jeon Y; Choi SS; Lee PB; Kim YC; Suh JH; Sim SE; Song SO; Ko Y; Yu JM; Min K; Lee JH
Clin Ther; 2020 Dec; 42(12):2266-2279. PubMed ID: 33272643
[TBL] [Abstract][Full Text] [Related]
2. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.
Kim TE; Jeon JY; Gu N; Chang Kwon M; Kim MG
Clin Ther; 2018 Dec; 40(12):2112-2124. PubMed ID: 30497798
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
4. Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study.
Shin KH; Jeon JY; Jang K; Kim TE; Kim MG
Drug Des Devel Ther; 2018; 12():3449-3457. PubMed ID: 30349198
[TBL] [Abstract][Full Text] [Related]
5. A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain.
Kang SM; Hong JH; Ku BJ
Medicine (Baltimore); 2023 Apr; 102(17):e33701. PubMed ID: 37115054
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial.
Han KA; Lee YH; Son HS; Song KH; Kim SY; Chung CH; Jang HC; Lee KW; Cha BY; Song KH; Ko YK; Lee PB; Kim BJ; Kim S; An T; Kim YC
Clin J Pain; 2022 Feb; 38(5):343-350. PubMed ID: 35220330
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial.
Huffman CL; Goldenberg JN; Weintraub J; Sanin L; Driscoll J; Yang R; Chew ML; Scavone JM
Clin J Pain; 2017 Jul; 33(7):569-578. PubMed ID: 27753650
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
Gilron I; Wajsbrot D; Therrien F; Lemay J
Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
[TBL] [Abstract][Full Text] [Related]
9. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials.
Onakpoya IJ; Thomas ET; Lee JJ; Goldacre B; Heneghan CJ
BMJ Open; 2019 Jan; 9(1):e023600. PubMed ID: 30670513
[TBL] [Abstract][Full Text] [Related]
10. Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.
Arnold LM; Arsenault P; Huffman C; Patrick JL; Messig M; Chew ML; Sanin L; Scavone JM; Pauer L; Clair AG
Curr Med Res Opin; 2014 Oct; 30(10):2069-83. PubMed ID: 24867298
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
Wallace MS; Irving G; Cowles VE
Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
Simpson DM; Rice AS; Emir B; Landen J; Semel D; Chew ML; Sporn J
Pain; 2014 Oct; 155(10):1943-54. PubMed ID: 24907403
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial.
Markman J; Resnick M; Greenberg S; Katz N; Yang R; Scavone J; Whalen E; Gregorian G; Parsons B; Knapp L
J Neurol; 2018 Dec; 265(12):2815-2824. PubMed ID: 30242745
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study.
Baron R; Martin-Mola E; Müller M; Dubois C; Falke D; Steigerwald I
Pain Pract; 2015 Jun; 15(5):455-70. PubMed ID: 24738609
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial.
van Seventer R; Bach FW; Toth CC; Serpell M; Temple J; Murphy TK; Nimour M
Eur J Neurol; 2010 Aug; 17(8):1082-9. PubMed ID: 20236172
[TBL] [Abstract][Full Text] [Related]
18. Perioperative pregabalin for reducing pain, analgesic consumption, and anxiety and enhancing sleep quality in elective neurosurgical patients: a prospective, randomized, double-blind, and controlled clinical study.
Shimony N; Amit U; Minz B; Grossman R; Dany MA; Gonen L; Kandov K; Ram Z; Weinbroum AA
J Neurosurg; 2016 Dec; 125(6):1513-1522. PubMed ID: 26871201
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.
Huffman C; Stacey BR; Tuchman M; Burbridge C; Li C; Parsons B; Pauer L; Scavone JM; Behar R; Yurkewicz L
Clin J Pain; 2015 Nov; 31(11):946-58. PubMed ID: 25565583
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.
Dou Z; Jiang Z; Zhong J
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e57-e64. PubMed ID: 25530068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
